青少年和年轻成年癌症幸存者的vaping行为:一个范围审查

相关实验视频

Updated: Jun 10, 2025

06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

Colter K Clayton^1,2, Nele Loecher¹, Rachel T Webster¹

¹St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Pediatric blood & cancer

|October 12, 2024

概括

吸烟在青少年和年轻成人 (AYA) 癌症幸存者中很常见,患病率从2%到46%不等. 这种行为与医疗问题,抑郁症和其他危险的健康习惯有关.

科学领域:

在瘤学瘤学.
公共卫生公共卫生
行为科学行为科学

背景情况:

青少年和年轻成人 (AYA) 癌症幸存者面临着独特的健康挑战,并容易发生危险行为.
电子烟 (电子烟使用) 在AYA中越来越令人担忧,但癌症幸存者的患病率和相关健康问题未得到充分研究.

研究的目的:

在AYA癌症幸存者 (年龄13-39岁) 中进行有关vaping的现有文献的范围审查.
为了确定这种脆弱人群中电子烟的流行率,相关性和相关的疾病.

主要方法:

在PubMed,科学网,PsycINFO和Scopus中进行了系统的数据库搜索.
包括的研究集中在13-39岁的癌症诊断或病史的个体的电子烟行为上.
八项横截面研究符合审查的资格标准.

主要成果:

在AYA癌症幸存者中使用电子烟的患病率在不同研究中差异很大,从2%到46%不等.
电子烟与医疗因素 (例如,癌症治疗的晚期影响),心理社会问题 (例如,抑郁症),人口因素 (例如,年轻年龄,男性性别) 和其他风险行为 (例如,吸烟) 相关.
有限的研究专门针对年轻的幸存者 (18岁以下) 的vaping.

结论:

现有研究强调了AYA癌症幸存者的vaping流行率和相关因素的显著变化.
进一步的研究至关重要,以了解电子烟对这一群体的影响,特别是对年轻的幸存者.
解决蒸汽行为对于改善AYA癌症幸存者的长期健康结果至关重要.

关键词:

这是一个MeSH术语.癌症幸存者癌症幸存者审查审查审查审查审查审查使用物质使用物质.电子烟 (vaping) 是一种电子烟.年轻的成年人年轻的成年人

相关概念视频

01:29

Stimulants

162

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

162

02:49

Cancer Therapies

7.6K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

7.6K

01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

203

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

203

01:21

Cancer Survival Analysis

328

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

328

02:56

Treatment Resistant Cancers

3.3K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...